Literature DB >> 4941553

Metabolism of 4-N-hydroxy-cytidine in Escherichia coli.

R B Trimble, F Maley.   

Abstract

4-N-hydroxy-cytidine was found to substitute for uridine as a pyrimidine supplement for the growth of Escherichia coli Bu(-). Measurement of the incorporation of 4-N-hydroxy-cytidine-2-(14)C into ribonucleic acid and deoxyribonucleic acid revealed that this compound was converted to cytidine or uridine before utilization. Two pathways for metabolism were considered: (i) the reduction of 4-N-hydroxy-cytidine to cytidine followed by deamination, (ii) the direct hydrolysis of hydroxylamine from 4-N-hydroxy-cytidine to yield uridine. A threefold increase in cytidine (deoxycytidine) deaminase (EC 3.5.4.5) activity, when the cells were grown on 4-N-hydroxy-cytidine, suggested the involvement of this enzyme. More direct proof was obtained by purifying the deaminase 185-fold and finding that it released hydroxylamine from 4-N-hydroxy-cytidine at one-fiftieth the rate at which ammonia was removed from cytidine. This result is consistent with the slower rate of growth of the Bu(-) cells on 4-N-hydroxy-cytidine than cytidine and suggests that the second pathway is the major route for utilization of this compound.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4941553      PMCID: PMC247043          DOI: 10.1128/jb.108.1.145-153.1971

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

1.  NUCLEOTIDES. 48. THE REACTION OF HYDROXYLAMINE WITH CYTOSINE AND RELATED COMPOUNDS.

Authors:  D M BROWN; P SCHELL
Journal:  J Chem Soc       Date:  1965-01

2.  Hydroxylamine as a mutagenic and inactivating agent.

Authors:  E FREESE; E BAUTZ-FREESE; E BAUTZ
Journal:  J Mol Biol       Date:  1961-04       Impact factor: 5.469

3.  Studies on the biosynthesis of bacterial and viral pyrimidines. IV. Utilization of pyrimidine bases and nucleosides by bacterial mutants.

Authors:  S S COHEN; J LICHTENSTEIN; H D BARNER; M GREEN
Journal:  J Biol Chem       Date:  1957-10       Impact factor: 5.157

4.  Nucleic acid metabolism in regenerating rat liver. I. The rate of deoxyribonucleic acid synthesis in vivo.

Authors:  L I HECHT; V R POTTER
Journal:  Cancer Res       Date:  1956-11       Impact factor: 12.701

5.  The purine and pyrimidine composition of deoxypentose nucleic acids.

Authors:  G R WYATT
Journal:  Biochem J       Date:  1951-05       Impact factor: 3.857

6.  Determination of hydroxylamine with Nessler reagent.

Authors:  W N Fishbein
Journal:  Anal Chim Acta       Date:  1967-04       Impact factor: 6.558

7.  Significance of ribonucleotide reduction in the biosynthesis of deoxyribonucleotides in Escherichia coli.

Authors:  O Karlström; A Larsson
Journal:  Eur J Biochem       Date:  1967-12

8.  A simple and sensitive method for the measurement of deoxycytidylate deaminase activity.

Authors:  N Ressler
Journal:  Clin Chem       Date:  1969-07       Impact factor: 8.327

9.  Inhibition of the biosynthesis of thymidylic acid by 4-N-Hydroxy-2'-deoxycytidine in L5178Y leukemic cells.

Authors:  D J Nelson; C E Carter
Journal:  Mol Pharmacol       Date:  1966-05       Impact factor: 4.436

10.  The incorporation of precursors into chick embryo DNA in the presence of 4 N-hydroxy-deoxycytidine and 4 N-hydroxy-5-methyl-deoxycytidine.

Authors:  F Maley
Journal:  Biochem Z       Date:  1965-08-19
View more
  2 in total

1.  An Engineered Cytidine Deaminase for Biocatalytic Production of a Key Intermediate of the Covid-19 Antiviral Molnupiravir.

Authors:  Ashleigh J Burke; William R Birmingham; Ying Zhuo; Thomas W Thorpe; Bruna Zucoloto da Costa; Rebecca Crawshaw; Ian Rowles; James D Finnigan; Carl Young; Gregory M Holgate; Mark P Muldowney; Simon J Charnock; Sarah L Lovelock; Nicholas J Turner; Anthony P Green
Journal:  J Am Chem Soc       Date:  2022-02-28       Impact factor: 15.419

Review 2.  A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.

Authors:  Prerna Malik; Sonika Jain; Pankaj Jain; Jyoti Kumawat; Jaya Dwivedi; Dharma Kishore
Journal:  Arch Pharm (Weinheim)       Date:  2022-01-17       Impact factor: 4.613

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.